Plasma HIV-1 RNA levels during antiretroviral therapy: how low is low enough?
- PMID: 22238162
- PMCID: PMC3275763
- DOI: 10.1093/cid/cir933
Plasma HIV-1 RNA levels during antiretroviral therapy: how low is low enough?
Comment on
-
Plasma HIV-1 RNA detection below 50 copies/ml and risk of virologic rebound in patients receiving highly active antiretroviral therapy.Clin Infect Dis. 2012 Mar 1;54(5):724-32. doi: 10.1093/cid/cir936. Epub 2012 Jan 11. Clin Infect Dis. 2012. PMID: 22238167
References
-
- Murray JS, Elashoff MR, Iacono-Connors LC, Cvetkovich TA, Struble KA. The use of plasma HIV RNA as a study endpoint in efficacy trials of antiretroviral drugs. AIDS. 1999;13:797–804. - PubMed
-
- Doyle T, Smith C, Vitiello P, et al. Plasma HIV-1 detection below 50 copies/mL and risk of virologic rebound in patients receiving highly active antiretroviral therapy. Clin Infect Dis. 2012;54:724–32. - PubMed
-
- Nettles RE, Kieffer TL, Kwon P, et al. Intermittent HIV-1 viremia (Blips) and drug resistance in patients receiving HAART. JAMA. 2005;293:817–29. - PubMed
Publication types
MeSH terms
Grants and funding
- P0 AI27763/AI/NIAID NIH HHS/United States
- G08 LM008830/LM/NLM NIH HHS/United States
- K24 AI069994/AI/NIAID NIH HHS/United States
- G08LM008830-01/LM/NLM NIH HHS/United States
- U01 AI 694722/AI/NIAID NIH HHS/United States
- P30 AI027763/AI/NIAID NIH HHS/United States
- R01 AI066992-04A1/AI/NIAID NIH HHS/United States
- P30 AI060354/AI/NIAID NIH HHS/United States
- U19 AI096109/AI/NIAID NIH HHS/United States
- K24AI069994/AI/NIAID NIH HHS/United States
- R01 AI066992/AI/NIAID NIH HHS/United States
- 2P30 AI060354-06/AI/NIAID NIH HHS/United States
- R01 AI087145/AI/NIAID NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical